Satoshi Hashino
Sapporo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 44 publications
Author Correction: Enhanced mitochondrial oxidative metabolism in peripheral blood mononuclear cells is associated with fatty liver in obese young adults.
Journal: Scientific reports
Published: March 22, 2024
Nine-Year Trend in the Prevalence of Allergic Diseases and Their Associated Factors in Young Adults.
Nine-Year Trend in the Prevalence of Allergic Diseases and Their Associated Factors in Young Adults.
Journal: International archives of allergy and immunology
Published: July 05, 2023
Enhanced mitochondrial oxidative metabolism in peripheral blood mononuclear cells is associated with fatty liver in obese young adults.
Journal: Scientific reports
Published: October 10, 2022
Antiretroviral therapy achieved metabolic complete remission of hepatic AIDS related Epstein-Barr virus-associated smooth muscle tumor.
Journal: Antiviral therapy
Published: September 16, 2022
Prevalence of depressive symptoms and psychological distress in Japanese university-enrolled students before and during the coronavirus disease 2019 pandemic.
Journal: Psychiatry and clinical neurosciences
Published: May 17, 2021
A prospective trial of vaccine to prevent hepatitis B virus reactivation after hematopoietic stem cell transplantation.
Journal: Bone marrow transplantation
Published: October 05, 2019
Methotrexate-induced myelodysplasia mimicking myelodysplastic syndrome.
Journal: Blood research
Published: December 28, 2018
Successful treatment of primary immune thrombocytopenia accompanied by diabetes mellitus treated using clarithromycin followed by prednisolone.
Journal: Drug discoveries & therapeutics
Published: April 24, 2018
Associations of Current Wheeze and Body Mass Index with Perennial and Seasonal Allergic Rhinitis in Young Adults.
Journal: International archives of allergy and immunology
Published: January 09, 2018
Final 3-year Results of the Dasatinib Discontinuation Trial in Patients With Chronic Myeloid Leukemia Who Received Dasatinib as a Second-line Treatment.
Journal: Clinical lymphoma, myeloma & leukemia
Published: December 30, 2017
Last Updated: 09/26/2026